Pharmacokinetic And Pharmacodynamic Aspects Of Peyote And Mescaline: Clinical And Forensic Repercussions Read More > October 10, 2018
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug Read More > October 5, 2018
Advances and challenges in neuroimaging studies on the effects of serotonergic hallucinogens: Contributions of the resting brain. Read More > September 28, 2018
Whole-Brain Multimodal Neuroimaging Model Using Serotonin Receptor Maps Explains Non-linear Functional Effects of LSD Read More > September 27, 2018
Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression Read More > September 27, 2018
Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models Read More > September 25, 2018
Psychedelics and the new behaviourism: considering the integration of third-wave behaviour therapies with psychedelic-assisted therapy Read More > September 25, 2018
Psychoplastogens: A Promising Class of Plasticity-Promoting Neurotherapeutics Read More > September 19, 2018
